Azitromicina Normon Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

azitromicina normon filmuhúðuð tafla 500 mg

laboratorios normon s.a. - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg

Simvastatín Alvogen (Simvastatín Portfarma) Filmuhúðuð tafla 20 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

simvastatín alvogen (simvastatín portfarma) filmuhúðuð tafla 20 mg

alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 20 mg

Simvastatín Alvogen (Simvastatín Portfarma) Filmuhúðuð tafla 40 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

simvastatín alvogen (simvastatín portfarma) filmuhúðuð tafla 40 mg

alvogen ehf. - simvastatinum inn - filmuhúðuð tafla - 40 mg

Zitromax Filmuhúðuð tafla 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax filmuhúðuð tafla 500 mg

pfizer aps - azithromycinum díhýdrat - filmuhúðuð tafla - 500 mg

Zitromax Mixtúruduft, dreifa 40 mg/ml Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax mixtúruduft, dreifa 40 mg/ml

pfizer aps - azithromycinum díhýdrat - mixtúruduft, dreifa - 40 mg/ml

Optovite B12 Stungulyf, lausn 1000 míkróg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

optovite b12 stungulyf, lausn 1000 míkróg

laboratorios normon s.a. - cyanocobalaminum inn - stungulyf, lausn - 1000 míkróg

Pemazyre Evrópusambandið - íslenska - EMA (European Medicines Agency)

pemazyre

incyte biosciences distribution b.v. - pemigatinib - cholangiocarcinoma - Æxlishemjandi lyf - pemazyre monotherapy is indicated for the treatment of adults with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed  after at least one prior line of systemic therapy.

Zitromax Stofn fyrir innrennslisþykkni, lausn 500 mg Ísland - íslenska - LYFJASTOFNUN (Icelandic Medicines Agency)

zitromax stofn fyrir innrennslisþykkni, lausn 500 mg

pfizer aps - azithromycinum díhýdrat - stofn fyrir innrennslisþykkni, lausn - 500 mg

Lytgobi Evrópusambandið - íslenska - EMA (European Medicines Agency)

lytgobi

taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastic lyfjum - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.

Zykadia Evrópusambandið - íslenska - EMA (European Medicines Agency)

zykadia

novartis europharm limited - ceritinib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - zykadia er ætlað til meðferðar hjá fullorðnum sjúklingum með lungnakrabbamein (anaplastic lymphoma kinase (alk)) sem hefur áður fengið meðferð með crizotinibi.